CAS 1215281-19-8

Formel: C19H21BO7

InChl: InChI=1S/C19H21BO7/c1-24-16-8-6-12(9-14(16)20(22)23)5-7-15(21)13-10-17(25-2)19(27-4)18(11-13)26-3/h5-11,22-23H,1-4H3/b7-5+

InChI Key: AKNGHUAJAODDJA-FNORWQNLSA-N

SMILES: B(C1=C(C=CC(=C1)/C=C/C(=O)C2=CC(=C(C(=C2)OC)OC)OC)OC)(O)O

YK-3-237

CAS: 1215281-19-8

YK-3-237

Formel: C₁₉H₂₁BO₇

Reinheit: ≥95%

Molekulargewicht: 372.18

Ref: 54-BUP12933

(E)-(2-Methoxy-5-(3-oxo-3-(3,4,5-trimethoxyphenyl)prop-1-en-1-yl)phenyl)boronic acid

CAS: 1215281-19-8

Formel: C₁₉H₂₁BO₇

Reinheit: 97%

Farbe und Form: Solid

Molekulargewicht: 372.1768

Ref: IN-DA00A195

YK-3-237

CAS: 1215281-19-8

YK-3-237 (B-[2-Methoxy-5-[(1E)-3-oxo-3-(3,4,5-trimethoxyphenyl)-1-propen-1-yl]phenyl]boronic acid) reduces acetylation of mtp53 and exhibits anti-proliferative

Formel: C₁₉H₂₁BO₇

Reinheit: 99.47%

Farbe und Form: Solid

Molekulargewicht: 372.18

Ref: TM-T9320

YK 3-237

CAS: 1215281-19-8

YK 3-237 is a potent inhibitor of the p21 protein, which is involved in cell cycle regulation and apoptosis. YK 3-237 has been shown to inhibit the transcriptional activity of transcription polymerase chain (PCR) by binding to the RNA polymerase II enzyme. This inhibition prevents mda-mb-231 breast cancer cells from proliferating and induces apoptosis. YK 3-237 also inhibits epidermal growth factor, which may be involved in the development of cancerous tumors. It has been observed that YK 3-237 blocks angiogenesis, hiv infection and monoclonal antibody production in vitro.

Formel: C₁₉H₂₁BO₇

Reinheit: Min. 95%

Molekulargewicht: 372.18 g/mol

Ref: 3D-QYB28119